gallic acid has been researched along with erythromycin in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 3 (50.00) | 2.80 |
Authors | Studies |
---|---|
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Kreander, K; Tammela, P; Vuorela, P | 1 |
Campina, FF; Coutinho, HDM; Cunha, FAB; de A Menezes, IR; de Freitas, TS; Dos Santos, JFS; Siqueira-JĂșnior, JP; Tintino, SR | 1 |
Huang, H; Li, P; Liao, K; Liu, B; Liu, C; Su, W; Wang, Y; Zhou, Q | 1 |
Akyol, M; Guner, RY; Kozan, A | 1 |
Hossain, MA; Kang, J; Lee, KJ; Park, HC; Park, SC; Park, SW | 1 |
1 trial(s) available for gallic acid and erythromycin
Article | Year |
---|---|
A retrospective assessment and comparison of the effectiveness of benzoyl peroxide; the combination of topical niacinamide, gallic acid, and lauric acid; and the combination of benzoyl peroxide and erythromycin in acne vulgaris.
Topics: Acne Vulgaris; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Dermatologic Agents; Erythromycin; Gallic Acid; Gels; Humans; Lauric Acids; Niacinamide; Retrospective Studies; Treatment Outcome | 2020 |
5 other study(ies) available for gallic acid and erythromycin
Article | Year |
---|---|
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
A rapid screening method for detecting active compounds against erythromycin-resistant bacterial strains of Finnish origin.
Topics: Anti-Bacterial Agents; Coumarins; Drug Resistance, Bacterial; Erythromycin; Finland; Flavonoids; Gallic Acid; Humans; Hydroxybenzoates; Microbial Sensitivity Tests; Nephelometry and Turbidimetry; Penicillin G; Staphylococcus; Streptococcus pyogenes; Time Factors | 2005 |
In vitro e in silico evaluation of the inhibition of Staphylococcus aureus efflux pumps by caffeic and gallic acid.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Binding Sites; Caffeic Acids; Drug Resistance, Bacterial; Erythromycin; Ethidium; Gallic Acid; Genes, MDR; Microbial Sensitivity Tests; Molecular Docking Simulation; Multidrug Resistance-Associated Proteins; Norfloxacin; Protein Binding; Protein Conformation, alpha-Helical; Protein Interaction Domains and Motifs; Staphylococcus aureus; Thermodynamics | 2018 |
Pithecellobium clypearia extract enriched in gallic acid and luteolin has antibacterial activity against MRSA and reduces resistance to erythromycin, ceftriaxone sodium and levofloxacin.
Topics: Animals; Anti-Bacterial Agents; Ceftriaxone; Drug Resistance, Bacterial; Drug Synergism; Erythromycin; Fabaceae; Gallic Acid; Levofloxacin; Luteolin; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Plant Extracts; Staphylococcal Infections; Tandem Mass Spectrometry | 2020 |
In vitro synergistic potentials of novel antibacterial combination therapies against Salmonella enterica serovar Typhimurium.
Topics: Animals; Animals, Domestic; Anti-Bacterial Agents; Biofilms; Catechin; Cell Line; Cell Survival; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Erythromycin; Gallic Acid; Microbial Sensitivity Tests; Phenols; Rats; Salmonella Infections, Animal; Salmonella typhimurium; Serogroup | 2020 |